Requisite Capital Management, LLC Iovance Biotherapeutics, Inc. Transaction History

Requisite Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 05, 2019	SELL	$9.78 - $24.52 $1.42 Million - $3.56 Million	-145,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$8.41 - $11.26 $42,050 - $56,300	-5,000 Reduced 3.33%	145,000 $1.38 Million
Q4 2018 May 15, 2019	BUY	$7.51 - $11.93 $1.13 Million - $1.79 Million	150,000 New	150,000 $1.33 Million

343

247M

2.51M

3.5M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $589M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Requisite Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Requisite Capital Management, LLC with notifications on news.